Does Dr. AZIN ABAZARI have financial conflicts of interest?

Dr. AZIN ABAZARI (MD) has received a total of $1,089 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,089 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. AZIN ABAZARI?

According to CMS Open Payments data, Dr. AZIN ABAZARI received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($225), OYSTER POINT PHARMA ($160), and RXSIGHT ($144).

Does Dr. AZIN ABAZARI receive research grants or speaking fees?

Dr. AZIN ABAZARI has received $1,089 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. AZIN ABAZARI

MDReal-Time Hydrated

Specialty: Ophthalmology, Cornea and External Diseases Specialist

Practice Location: BOSTON, MA 02116

NPI Number: 1164625133

LIFETIME INDUSTRY VALUE

$1,089

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABAZARI is a verified Ophthalmology, Cornea and External Diseases Specialist practitioner based in BOSTON, MA.

Between 2021 and 2025, Dr. ABAZARI had an overall industry promotional and research financial footprint of $1,089 as recorded in the federal CMS Open Payments database.

$1,089 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABAZARI's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $225 (representing 20.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$225

20.6%

OYSTER POINT PHARMA

Rank 2

$160

14.7%

RXSIGHT

Rank 3

$144

13.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.